{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:52:29Z","timestamp":1794009149238,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP 21K16024"],"award-info":[{"award-number":["JP 21K16024"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pericoronary adipose tissue (PCAT) attenuation on coronary computed tomography angiography (CTA) is a non-invasive biomarker for pericoronary inflammation. We aimed to investigate the prognostic value of PCAT attenuation in patients with type 2 diabetes mellitus (T2DM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included 333 T2DM patients (mean age, 66\u00a0years; male patients, 211; mean body mass index, 25\u00a0kg\/m<jats:sup>2<\/jats:sup>) who underwent clinically indicated coronary CTA and examined their CT findings, coronary artery calcium score, pericardial fat volume, stenosis (&gt;\u200950% luminal narrowing), high-risk plaque features of low-attenuation plaque and\/or positive remodelling and\/or spotty calcification, and PCAT attenuation. We assessed PCAT attenuation in Hounsfield units (HU) of proximal 40-mm segments of the left anterior descending artery (LAD) and right coronary artery (RCA). Cardiovascular events were defined as cardiac death, hospitalisation for acute coronary syndrome, late coronary revascularisation, and hospitalisation for heart failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During a median follow-up of 4.0\u00a0years, we observed 31 cardiovascular events. LAD-PCAT attenuation was significantly higher in patients with cardiovascular events than in those without (\u2212\u00a068.5\u2009\u00b1\u20096.5 HU vs \u2212\u00a070.8\u2009\u00b1\u20096.1 HU, p\u2009=\u20090.045), whereas RCA-PCAT attenuation was not (p\u2009=\u20090.089). High LAD-PCAT attenuation (&gt;\u2009\u2212\u00a070.7 HU; median value) was significantly associated with cardiovascular events in a model that included adverse CTA findings, such as significant stenosis and\/or high-risk plaque (hazard ratio; 2.69, 95% confidence interval; 1.17\u20130.20, p\u2009=\u20090.020). After adding LAD-PCAT attenuation to the adverse CTA findings, the C-statistic and global chi-square values increased significantly from 0.65 to 0.70 (p\u2009=\u20090.037) and 10.9\u201315.0 (p\u2009=\u20090.043), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In T2DM patients undergoing clinically indicated coronary CTA, high LAD-PCAT attenuation could significantly predict cardiovascular events. This suggests that assessing LAD-PCAT attenuation can help physicians identify high-risk T2DM patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12933-022-01478-9","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T16:14:31Z","timestamp":1647620071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Keishi","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"issue":"15","key":"1478_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","volume":"117","author":"TK Schramm","year":"2008","unstructured":"Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, Hansen ML, Folke F, Buch P, Madsen M, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117(15):1945\u201354.","journal-title":"Circulation"},{"issue":"11","key":"1478_CR2","first-page":"e563","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563\u201395.","journal-title":"Circulation"},{"issue":"9","key":"1478_CR3","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.2337\/dc06-1136","volume":"29","author":"KM Narayan","year":"2006","unstructured":"Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: US, 2005\u20132050. Diabetes Care. 2006;29(9):2114\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"1478_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/hrt.2007.121921","volume":"94","author":"AJ Scholte","year":"2008","unstructured":"Scholte AJ, Schuijf JD, Kharagjitsingh AV, Jukema JW, Pundziute G, van der Wall EE, Bax JJ. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008;94(3):290\u20135.","journal-title":"Heart"},{"issue":"3","key":"1478_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jcct.2020.11.001","volume":"15","author":"J Narula","year":"2021","unstructured":"Narula J, Chandrashekhar Y, Ahmadi A, Abbara S, Berman DS, Blankstein R, Leipsic J, Newby D, Nicol ED, Nieman K, et al. SCCT 2021 expert consensus document on coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2021;15(3):192\u2013217.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"4","key":"1478_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","volume":"66","author":"S Motoyama","year":"2015","unstructured":"Motoyama S, Ito H, Sarai M, Kondo T, Kawai H, Nagahara Y, Harigaya H, Kan S, Anno H, Takahashi H, et al. Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol. 2015;66(4):337\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1478_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jcmg.2019.06.019","volume":"13","author":"D Andreini","year":"2020","unstructured":"Andreini D, Magnoni M, Conte E, Masson S, Mushtaq S, Berti S, Canestrari M, Casolo G, Gabrielli D, Latini R, et al. Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events. JACC Cardiovasc Imaging. 2020;13(8):1704\u201317.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7 Pt 2","key":"1478_CR8","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jcmg.2018.02.025","volume":"12","author":"DA Halon","year":"2019","unstructured":"Halon DA, Lavi I, Barnett-Griness O, Rubinshtein R, Zafrir B, Azencot M, Lewis BS. Plaque morphology as predictor of late plaque events in patients with asymptomatic type 2 diabetes: a long-term observational study. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1353\u201363.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1478_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2658","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, Margaritis M, Shirodaria C, Kampoli AM, Akoumianakis I, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aal2658.","journal-title":"Sci Transl Med"},{"issue":"10151","key":"1478_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","volume":"392","author":"EK Oikonomou","year":"2018","unstructured":"Oikonomou EK, Marwan M, Desai MY, Mancio J, Alashi A, Hutt Centeno E, Thomas S, Herdman L, Kotanidis CP, Thomas KE, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392(10151):929\u201339.","journal-title":"Lancet"},{"key":"1478_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(21)02728-5","author":"PA van Diemen","year":"2021","unstructured":"van Diemen PA, Bom MJ, Driessen RS, Schumacher SP, Everaars H, de Winter RW, van de Ven PM, Freiman M, Goshen L, Heijtel D, et al. Prognostic value of RCA pericoronary adipose tissue CT-attenuation beyond high-risk plaques, plaque volume, and ischemia. JACC Cardiovasc Imaging. 2021. https:\/\/doi.org\/10.1016\/S0735-1097(21)02728-5.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"1478_CR12","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/eurjpc\/zwab120","volume":"28","author":"K Ichikawa","year":"2022","unstructured":"Ichikawa K, Miyoshi T, Osawa K, Miki T, Toda H, Ejiri K, Yoshida M, Nakamura K, Morita H, Ito H. Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease. Eur J Prev Cardiol. 2022;28(18):2059\u201366.","journal-title":"Eur J Prev Cardiol"},{"issue":"Suppl 1","key":"1478_CR13","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","volume":"33","author":"A American Diabetes","year":"2010","unstructured":"American Diabetes A. Standards of medical care in diabetes\u20132010. Diabetes Care. 2010;33(Suppl 1):S11-61.","journal-title":"Diabetes Care"},{"issue":"8","key":"1478_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.5551\/jat.19356","volume":"21","author":"K Nishimura","year":"2014","unstructured":"Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study. J Atheroscler Thromb. 2014;21(8):784\u201398.","journal-title":"J Atheroscler Thromb"},{"key":"1478_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijcard.2020.09.060","volume":"324","author":"K Suruga","year":"2021","unstructured":"Suruga K, Miyoshi T, Kotani K, Ichikawa K, Miki T, Osawa K, Ejiri K, Toda H, Nakamura K, Morita H, et al. Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography. Int J Cardiol. 2021;324:193\u20138.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1478_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jcct.2016.04.005","volume":"10","author":"RC Cury","year":"2016","unstructured":"Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, Dill KE, Jacobs JE, Maroules CD, Rubin GD, et al. CAD-RADS(TM) coronary artery disease\u2014reporting and data system. an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2016;10(4):269\u201381.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1","key":"1478_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-020-01192-4","volume":"20","author":"K Ichikawa","year":"2021","unstructured":"Ichikawa K, Miyoshi T, Osawa K, Miki T, Toda H, Ejiri K, Yoshida M, Nanba Y, Yoshida M, Nakamura K, et al. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"1478_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jcmg.2016.10.024","volume":"10","author":"RV Shah","year":"2017","unstructured":"Shah RV, Anderson A, Ding J, Budoff M, Rider O, Petersen SE, Jensen MK, Koch M, Allison M, Kawel-Boehm N, et al. Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: the multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging. 2017;10(9):1016\u201327.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1478_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijcard.2020.06.008","volume":"319","author":"X Dai","year":"2020","unstructured":"Dai X, Yu L, Lu Z, Shen C, Tao X, Zhang J. Serial change of perivascular fat attenuation index after statin treatment: Insights from a coronary CT angiography follow-up study. Int J Cardiol. 2020;319:144\u20139.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1478_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","volume":"38","author":"MC Calle","year":"2012","unstructured":"Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38(3):183\u201391.","journal-title":"Diabetes Metab"},{"issue":"10","key":"1478_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jcmg.2018.04.009","volume":"11","author":"U Kim","year":"2018","unstructured":"Kim U, Leipsic JA, Sellers SL, Shao M, Blanke P, Hadamitzky M, Kim YJ, Conte E, Andreini D, Pontone G, et al. Natural history of diabetic coronary atherosclerosis by quantitative measurement of serial coronary computed tomographic angiography: results of the PARADIGM study. JACC Cardiovasc Imaging. 2018;11(10):1461\u201371.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1478_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2022.01.002","author":"Y Yu","year":"2022","unstructured":"Yu Y, Ding X, Yu L, Dai X, Wang Y, Zhang J. Increased coronary pericoronary adipose tissue attenuation in diabetic patients compared to non-diabetic controls: a propensity score matching analysis. J Cardiovasc Comput Tomogr. 2022. https:\/\/doi.org\/10.1016\/j.jcct.2022.01.002.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"8","key":"1478_CR23","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jcmg.2021.02.026","volume":"14","author":"PA van Diemen","year":"2021","unstructured":"van Diemen PA, Bom MJ, Driessen RS, Schumacher SP, Everaars H, de Winter RW, van de Ven PM, Freiman M, Goshen L, Heijtel D, et al. Prognostic value of RCA pericoronary adipose tissue CT-attenuation beyond high-risk plaques, plaque volume, and ischemia. JACC Cardiovasc Imaging. 2021;14(8):1598\u2013610.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"1478_CR24","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1007\/s00330-020-07069-0","volume":"30","author":"R Ma","year":"2020","unstructured":"Ma R, Ties D, van Assen M, Pelgrim GJ, Sidorenkov G, van Ooijen PMA, van der Harst P, van Dijk R, Vliegenthart R. Towards reference values of pericoronary adipose tissue attenuation: impact of coronary artery and tube voltage in coronary computed tomography angiography. Eur Radiol. 2020;30(12):6838\u201346.","journal-title":"Eur Radiol"},{"issue":"11","key":"1478_CR25","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jcmg.2015.12.027","volume":"9","author":"P Blanke","year":"2016","unstructured":"Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, Gransar H, Achenbach S, Berman DS, Budoff MJ, et al. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes mellitus. JACC Cardiovasc Imaging. 2016;9(11):1280\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"1478_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.jcmg.2019.09.011","volume":"13","author":"SE Lee","year":"2020","unstructured":"Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, et al. Differences in progression to obstructive lesions per high-risk plaque features and plaque volumes with CCTA. JACC Cardiovasc Imaging. 2020;13(6):1409\u201317.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"1478_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ehjci\/jez013","volume":"20","author":"M Goeller","year":"2019","unstructured":"Goeller M, Tamarappoo BK, Kwan AC, Cadet S, Commandeur F, Razipour A, Slomka PJ, Gransar H, Chen X, Otaki Y, et al. Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging. 2019;20(6):636\u201343.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"1478_CR28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/eurheartj\/ehz474","volume":"41","author":"C Antoniades","year":"2020","unstructured":"Antoniades C, Antonopoulos AS, Deanfield J. Imaging residual inflammatory cardiovascular risk. Eur Heart J. 2020;41(6):748\u201358.","journal-title":"Eur Heart J"},{"issue":"43","key":"1478_CR29","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1093\/eurheartj\/ehz592","volume":"40","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Williams MC, Kotanidis CP, Desai MY, Marwan M, Antonopoulos AS, Thomas KE, Thomas S, Akoumianakis I, Fan LM, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40(43):3529\u201343.","journal-title":"Eur Heart J"},{"issue":"9","key":"1478_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jamacardio.2019.2589","volume":"4","author":"YA Elnabawi","year":"2019","unstructured":"Elnabawi YA, Oikonomou EK, Dey AK, Mancio J, Rodante JA, Aksentijevich M, Choi H, Keel A, Erb-Alvarez J, Teague HL, et al. Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index. JAMA Cardiol. 2019;4(9):885\u201391.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"1478_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","volume":"39","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, Hainer J, Bibbo CF, Dorbala S, Blankstein R, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018;39(10):840\u20139.","journal-title":"Eur Heart J"},{"issue":"3","key":"1478_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ejhf.1671","volume":"22","author":"JH Yang","year":"2020","unstructured":"Yang JH, Obokata M, Reddy YNV, Redfield MM, Lerman A, Borlaug BA. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(3):432\u201341.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1478_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ehjci\/jeaa023","volume":"21","author":"CH Nomura","year":"2020","unstructured":"Nomura CH, Assuncao-Jr AN, Guimaraes PO, Liberato G, Morais TC, Fahel MG, Giorgi MCP, Meneghetti JC, Parga JR, Dantas-Jr RN, et al. Association between perivascular inflammation and downstream myocardial perfusion in patients with suspected coronary artery disease. Eur Heart J Cardiovasc Imaging. 2020;21(6):599\u2013605.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1478_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2021.05.040","volume":"336","author":"MC Pasqualetto","year":"2021","unstructured":"Pasqualetto MC, Tuttolomondo D, Cutruzzola A, Niccoli G, Dey D, Greco A, Martini C, Irace C, Rigo F, Gaibazzi N. Human coronary inflammation by computed tomography: relationship with coronary microvascular dysfunction. Int J Cardiol. 2021;336:8\u201313.","journal-title":"Int J Cardiol"},{"issue":"22","key":"1478_CR35","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMe1512602","volume":"373","author":"JR Ingelfinger","year":"2015","unstructured":"Ingelfinger JR, Rosen CJ. Cardiovascular risk and sodium-glucose cotransporter 2 inhibition in type 2 diabetes. N Engl J Med. 2015;373(22):2178\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"1478_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01478-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01478-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01478-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T13:32:55Z","timestamp":1674999175000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01478-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01478-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Okayama University Hospital and conducted in accordance with the principles contained within the Declaration of Helsinki. All patients enrolled in the study provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests associated with this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}